tm
Seeing Is Believing
tm
Seeing Is Believing
ARCT is currently covered by 11 analysts with an average potential upside of $20.79 (84.13%) backed by displayed 46 price targets and 73 ratings.
Analysts average stock forecasts to be materialized ratio is 67.04% with an average time for these price targets to be met of 153.83 days.
Highest price target for ARCT is 36, Lowest price target is 13, average price target is 24.5.
Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 27-Sep-2023. First documented stock forecast 21-Jun-2016.
Currently, out of the existing stock ratings of ARCT - 14 which are a Buy (58.33%), 5 which are a Hold (20.83%), 5 which are a Sell (20.83%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
51
$25.45 (99.61%)
51
2 months 4 days ago
1/10 (10%)
$17.4 (61.14%)
17
Buy
54
$29.76 (122.77%)
54
3 months 9 days ago
0/3 (0%)
$20.75 (73.61%)
Buy
36
4 months 17 days ago
1/1 (100%)
$15.83 (78.48%)
110
Buy
35
$10.76 (44.39%)
1 years 17 days ago
1/2 (50%)
$33.9 (84.10%)
242
Hold
35
$10.76 (44.39%)
29
1 years 28 days ago
2/3 (66.67%)
$14.95 (37.02%)
319
What is ARCT (Arcturus Therapeutics Holdings) average time for price targets to be met?
Which analyst has the current highest performing score on ARCT (Arcturus Therapeutics Holdings) with a proven track record?
Which analyst has the most public recommendations on ARCT (Arcturus Therapeutics Holdings)?
Which analyst is the currently most bullish on ARCT (Arcturus Therapeutics Holdings)?
Which analyst is the currently most reserved on ARCT (Arcturus Therapeutics Holdings)?
